IVF Devices and Consumables Market Expected to Reach $4,972 Million, by 2023, Globally

PORTLAND, Oregon and PUNE, India, October 2, 2017 /PRNewswire/ --

According to a new report published by Allied Market Research, titled, "IVF Devices and Consumables Market: Global Opportunity Analysis and Industry Forecast, 2014-2023 [https://www.alliedmarketresearch.com/in-vitro-fertilization-market ], " the global IVF devices and consumables market was valued at $1,506 million in 2016, and is projected to reach $4,972 million by 2023, growing at a CAGR of 18.3% from 2017 to 2023. Europe is anticipated to be the highest revenue contributor throughout the forecast period.

Do Enquiry for Sample Report@ https://www.alliedmarketresearch.com/request-sample/124

In vitro fertilization (IVF) is an assisted reproductive technology (ART) procedure. It is the process of fertilization, which includes eggs extraction, sperm cell sample retrieval, and then manually combining an egg and sperm in laboratory settings to form an embryo. The embryo(s) are then transferred to the uterus for further gestation.

The IVF devices and consumables market is expected to witness a substantial growth in future owing to rise in incidence of infertility cases, growth in the trend of delayed pregnancies among women, technological advancements in IVF procedures, and increased occurrences of gamete donations. Furthermore, rise in disposable income & increase in awareness about IVF treatments among the general populace boosts the market.

Inadequate reimbursement policies associated with IVF treatment are anticipated to impede the market growth during the forecast period. However, growth in interest of single parents as well as same sex couples in experiencing parenthood through artificial reproductive technology (ART), especially IVF, is expected to present various opportunities for market expansion.

Do Enquiry before purchasing Report https://www.alliedmarketresearch.com/purchase-enquiry/124

In the instrument segment, cabinets, a capital IVF instrument accounted for nearly one-fourth of the share in 2016. In terms of reagents and media, cryopreservation media accounted for a global revenue of nearly 34% in 2016. Whereas, semen processing media segment is anticipated to exhibit a prominent growth rate owing to its crucial role in the preservation of sperm motility, which is one of the essential factors for a successful IVF procedure.

In the IVF devices and consumables end users market, IVF clinics generated revenue of $894 million in 2016, highest amongst all end users. The surgical centers segment is anticipated to exhibit prominent growth rate due to availability of various IVF procedures under one roof, development of IVF devices with advanced technologies, and the availability of a skilled workforce. By geography, Europe generated the highest revenue in the global IVF market in 2016.

KEY FINDINGS OF THE IVF DEVICES AND CONSUMABLES MARKET STUDY: 

        
        - Cabinets accounted for nearly one-fourth of the share of the global IVF devices
          and consumables market in 2016.
        - Ovum aspiration pumps are anticipated to grow with the highest CAGR throughout the
          forecast period.
        - Europe accounted for nearly two-fifths of the global IVF devices and consumables
          market in 2016.
        - Cryopreservation media accounted for a global revenue of nearly 34% in 2016.
        - Asia-Pacific is anticipated to be the fastest growing IVF devices and consumables
          market during the analysis period, followed by LAMEA.

According to Onkar Sumant, Team Lead, Healthcare at Allied Market Research, "Rise in incidence of fertility-related conditions has led to the need of assisted reproduction technologies. IVF is the key assisted reproduction technology that provides technologically advanced treatment to couples seeking assistance for infertility treatment."

The major companies profiled in the report include Cook Medical, Inc., Cooper Companies, Inc., Genea Biomedx, JXTG Holdings, Inc., Merck KGAA, Ovascience, Inc., Oxford Gene Technology, Progyny, Inc., Thermo Fisher Scientific, Inc., and Vitrolife AB.

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

        


        Contact: 
        Pankaj Kumar 
        5933 NE Win Sivers Drive 
        #205, Portland, OR 97220 
        United States 
        Direct: +1-503-894-6022 
        Toll Free: +1 (800) 792-5285 (U.S. & Canada) 

 

SOURCE Allied Market Research